genome
British researchers sequences 100,000 whole genomes
December 6, 2018Research and Development Matt Hancock, digital, genome, personalised medicnie
British researchers have sequenced 100,000 whole genomes as part of an effort to improve understanding of rare diseases and move …
AstraZeneca to sequence genomes to develop new drugs
April 22, 2016Medical Communications, Sales and Marketing AstraZeneca, Finland, Wellcome Trust, collaboration, genome, genomics, human longevity, institute for molecular medicine, sanger institute
AstraZeneca (LSE: AZN) has announced an integrated genomics initiative that aims to transform the drug discovery and development across is …
Genome-driven lung cancer trial launches
June 18, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, Genentech, MedImmune, Pfizer, genome, lung cancer
Amgen, Genentech, Pfizer, AstraZeneca and MedImmune – AstraZeneca’s global biologics R&D arm – have each put investigative treatments into a …
UK to launch DNA database
November 8, 2013Sales and Marketing DNA, UK, crispr, genome
Volunteers prepared to share their DNA with the rest of the world are being sought by scientists in the UK, …
Study boost for personalised cancer treatments
July 23, 2010Research and Development Cancer, genome, genomics, personalised medicine
A five-year study by scientists in the UK and US of the way genomes and cancer medicines interact has yielded …
First artificial life created
May 24, 2010Research and Development Cell biology, Venter, cell, genome
Scientists in the US have succeeded in developing the first living cell to be controlled entirely by synthetic DNA. The …
Huge drug discovery database launched
January 26, 2010Research and Development ChEMBLdb, Wellcome, genome, genomics
A huge online database of information on the properties and activities of drugs and drug-like small molecules and their targets …
Boehringer targets ‘genome guardian’ protein for cancer collaboration
January 19, 2010Research and Development Boehringer, Cancer, Priaxon, genome
Boehringer Ingelheim has signed a worldwide deal with Munich-based pharma firm Priaxon to find novel treatments for cancer. The firms …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
